0001203311-23-000065.txt : 20230609
0001203311-23-000065.hdr.sgml : 20230609
20230609185002
ACCESSION NUMBER: 0001203311-23-000065
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230607
FILED AS OF DATE: 20230609
DATE AS OF CHANGE: 20230609
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HIMES VAUGHN B
CENTRAL INDEX KEY: 0001361966
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 231006734
MAIL ADDRESS:
STREET 1: C/O SEATTLE GENETICS, INC.
STREET 2: 21823 30TH DRIVE SE
CITY: BOTHELL
STATE: WA
ZIP: 98021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seagen Inc.
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA
DATE OF NAME CHANGE: 20001116
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0407
4
2023-06-07
0
0001060736
Seagen Inc.
SGEN
0001361966
HIMES VAUGHN B
21823 30TH DRIVE SE
BOTHELL
WA
98021
0
1
0
0
Chief Technical Officer
1
Common Stock
2023-06-07
4
M
0
16215
41.04
A
60052
D
Common Stock
2023-06-07
4
S
0
16215
195.2865
D
43837
D
Common Stock
119471
I
by Trust
Non-Qualified Stock Option (right to buy)
41.04
2023-06-07
4
M
0
16215
0.0
D
2023-08-19
Common Stock
16215
0
D
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
The sales reported in this Form 4 were effected pursuant to a written plan, entered into on November 29, 2022, that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Reflects sales of common stock executed in multiple transactions at prices ranging from $195.00 to $195.60. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Options vested at a rate of 25% on 8/19/14 and monthly thereafter until all the options were fully vested on 8/19/17.
By: /s/ Jennifer Prosba For: Vaughn B Himes
2023-06-09